Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. （開啟新視窗）

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

來源‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

檢索‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 （開啟新視窗）

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. （開啟新視窗）

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

來源‎: Lancet 2018;391(10116):125-32.

檢索‎: PubMed 29126600

DOI碼‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 （開啟新視窗）

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. （開啟新視窗）

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

來源‎: Am J Perinatol 2013;30(5):407-13.

檢索‎: PubMed 23023559

DOI碼‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 （開啟新視窗）

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. （開啟新視窗）

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

來源‎: Am J Perinatol 2011;28(3):233-40.

檢索‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 （開啟新視窗）

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. （開啟新視窗）

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

來源‎: Lancet 2017;389(10084):2105-16.

檢索‎: PubMed 28456509

DOI碼‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 （開啟新視窗）

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. （開啟新視窗）

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

來源‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

檢索‎: PubMed 26698831

DOI碼‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 （開啟新視窗）

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. （開啟新視窗）

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

來源‎: Int J Gynaecol Obstet 2016;133(3):312-5.

檢索‎: PubMed 26952346

DOI碼‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 （開啟新視窗）

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. （開啟新視窗）

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

來源‎: Obstet Gynecol 2007;110(6):1270-8.

檢索‎: PubMed 18055720

DOI碼‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 （開啟新視窗）

The use of recombinant activated FVII in postpartum hemorrhage. （開啟新視窗）

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

來源‎: Clin Obstet Gynecol 2010;53(1):219-27.

檢索‎: PubMed 20142658

DOI碼‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 （開啟新視窗）

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. （開啟新視窗）

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

來源‎: J Perinat Med 2011;40(1):43-9.

檢索‎: PubMed 22017328

DOI碼‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 （開啟新視窗）

Postpartum hemorrhage: when uterotonics and sutures fail. （開啟新視窗）

James AH, McLintock C, Lockhart E.

來源‎: Am J Hematol 2012;87 Suppl 1:S16-22.

檢索‎: PubMed 22430921

DOI碼‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 （開啟新視窗）

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. （開啟新視窗）

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

來源‎: Int J Hematol 2012;95(1):57-63.

檢索‎: PubMed 22160834

DOI碼‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 （開啟新視窗）

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. （開啟新視窗）

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

來源‎: J Thromb Haemost 2015;13(4):520-9.

檢索‎: PubMed 25594352

DOI碼‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 （開啟新視窗）

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. （開啟新視窗）

Lim Y, Loo CC, Chia V, Fun W.

來源‎: Int J Gynaecol Obstet 2004;87(2):178-9.

檢索‎: PubMed 15491576

DOI碼‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 （開啟新視窗）

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. （開啟新視窗）

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

來源‎: Br J Haematol 2001;114(1):174-6.

檢索‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 （開啟新視窗）

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. （開啟新視窗）

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

來源‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

檢索‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 （開啟新視窗）

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. （開啟新視窗）

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

來源‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

檢索‎: PubMed 22489992

DOI碼‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 （開啟新視窗）

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. （開啟新視窗）

Pepas LP, Arif-Adib M, Kadir RA.

來源‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

檢索‎: PubMed 17018493

DOI碼‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 （開啟新視窗）

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. （開啟新視窗）

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

來源‎: Anesth Analg 2009;109(6):1908-15.

檢索‎: PubMed 19923520

DOI碼‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 （開啟新視窗）

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. （開啟新視窗）

Prosper SC, Goudge CS, Lupo VR.

來源‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

檢索‎: PubMed 17267882

DOI碼‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 （開啟新視窗）

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. （開啟新視窗）

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

來源‎: Transfus Med 2012;22(5):344-9.

檢索‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 （開啟新視窗）

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. （開啟新視窗）

Bell SF, Rayment R, Collins PW, Collis RE.

來源‎: Int J Obstet Anesth 2010;19(2):218-23.

檢索‎: PubMed 20194010

DOI碼‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 （開啟新視窗）

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. （開啟新視窗）

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

來源‎: Br J Anaesth 2012;108(6):984-9.

檢索‎: PubMed 22490316

DOI碼‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 （開啟新視窗）

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. （開啟新視窗）

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

來源‎: J Nippon Med Sch 2014;81(2):94-6.

檢索‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 （開啟新視窗）

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. （開啟新視窗）

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

來源‎: Haemophilia 2012;18(1):25-33.

檢索‎: PubMed 21624012

DOI碼‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 （開啟新視窗）

Tisseel for management of traumatic postpartum haemorrhage. （開啟新視窗）

Dhulkotia JS, Alazzam M, Galimberti A.

來源‎: Arch Gynecol Obstet 2009;279(3):437-9.

檢索‎: PubMed 18985368

DOI碼‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 （開啟新視窗）

Uterine packing with chitosan-covered tamponade to treat postpartum hemorrhage. （開啟新視窗）

Henrich W, Dückelmann A, Braun T, Hinkson L

來源‎: Am J Obstet Gynecol 2024;230(3S):S1061-65.

檢索‎: PubMed 38462249

DOI碼‎: 10.1016/j.ajog.2022.11.1297

https://pubmed.ncbi.nlm.nih.gov/38462249/ （開啟新視窗）

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. （開啟新視窗）

Moriarty KT, Premila S, Bulmer PJ.

來源‎: BJOG 2008;115(6):793-5.

檢索‎: PubMed 18355369

DOI碼‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 （開啟新視窗）

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. （開啟新視窗）

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

來源‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

檢索‎: PubMed 28219621

DOI碼‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 （開啟新視窗）

Fibrin sealant for management of complicated obstetric lacerations. （開啟新視窗）

Whiteside JL, Asif RB, Novello RJ.

來源‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

檢索‎: PubMed 20093858

DOI碼‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 （開啟新視窗）

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. （開啟新視窗）

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

來源‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

檢索‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 （開啟新視窗）

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. （開啟新視窗）

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

來源‎: Int J Obstet Anesth 2011;20(4):293-8.

檢索‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 （開啟新視窗）

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. （開啟新視窗）

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

來源‎: Obstet Gynecol Surv 2012;67(7):426-35.

檢索‎: PubMed 22926249

DOI碼‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 （開啟新視窗）

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? （開啟新視窗）

Karlsson O, Jeppsson A, Hellgren M.

來源‎: Int J Obstet Anesth 2014;23(1):10-7.

檢索‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 （開啟新視窗）

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. （開啟新視窗）

Levy JH, Welsby I, Goodnough LT.

來源‎: Transfusion 2014;54(5):1389-405.

檢索‎: PubMed 24117955

DOI碼‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 （開啟新視窗）

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. （開啟新視窗）

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

來源‎: Int J Obstet Anesth 2015;24(2):174-9.

檢索‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 （開啟新視窗）

Haemostatic monitoring during postpartum haemorrhage and implications for management. （開啟新視窗）

Solomon C, Collis RE, Collins PW.

來源‎: Br J Anaesth 2012;109(6):851-63.

檢索‎: PubMed 23075633

DOI碼‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 （開啟新視窗）